SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 141 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $869,635 | -12.8% | 37,614 | -1.1% | 0.00% | – |
Q2 2023 | $997,698 | +14.6% | 38,051 | +12.5% | 0.00% | – |
Q1 2023 | $870,296 | +35.9% | 33,811 | +37.3% | 0.00% | – |
Q4 2022 | $640,392 | -16.5% | 24,621 | -8.5% | 0.00% | – |
Q3 2022 | $767,000 | +9.6% | 26,895 | -5.4% | 0.00% | – |
Q2 2022 | $700,000 | -43.0% | 28,429 | +30.6% | 0.00% | – |
Q1 2022 | $1,228,000 | -9.0% | 21,769 | +0.0% | 0.00% | – |
Q4 2021 | $1,349,000 | -2.1% | 21,766 | +0.2% | 0.00% | – |
Q3 2021 | $1,378,000 | -6.5% | 21,715 | +21.4% | 0.00% | – |
Q2 2021 | $1,474,000 | +41.3% | 17,886 | +26.3% | 0.00% | – |
Q1 2021 | $1,043,000 | +307.4% | 14,166 | +301.2% | 0.00% | – |
Q4 2020 | $256,000 | +73.0% | 3,531 | +13.4% | 0.00% | – |
Q3 2020 | $148,000 | -12.9% | 3,113 | -23.1% | 0.00% | – |
Q2 2020 | $170,000 | +314.6% | 4,049 | +162.8% | 0.00% | – |
Q1 2020 | $41,000 | -95.7% | 1,541 | -93.8% | 0.00% | – |
Q4 2019 | $954,000 | +23750.0% | 24,871 | +12654.4% | 0.00% | – |
Q3 2019 | $4,000 | – | 195 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 7,281,307 | $347,100,000 | 32.35% |
BVF INC/IL | 2,053,991 | $97,914,000 | 5.33% |
Samsara BioCapital, LLC | 398,017 | $18,973,000 | 5.29% |
Orbimed Advisors | 7,406,307 | $353,059,000 | 4.44% |
Consonance Capital Management LP | 602,732 | $28,732,000 | 3.50% |
Boxer Capital, LLC | 2,075,905 | $98,958,000 | 3.42% |
Perceptive Advisors | 3,481,148 | $165,946,000 | 2.42% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,234,262 | $58,837,000 | 1.43% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 974,915 | $46,474,000 | 0.95% |
HighVista Strategies LLC | 11,477 | $547,000 | 0.40% |